Activation of toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Liang, Zhaoduan ^a,b   Wu, Siyu ^a,b   Li, Yuye ^a,b   He, Li ^a,b   Wu, Minhao ^a,b   Jiang, Lifang ^a,b   Feng, Lianqiang ^a,b   Zhang, Ping ^a,b   Huang, Xi ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; I KAPPA B KINASE INHIBITOR; INTERLEUKIN 28; INTERLEUKIN 28A; INTERLEUKIN 28B; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; LIGAND; PRIMER DNA; TLR3 PROTEIN, HUMAN; VIRUS RNA;

ARTICLE; CANCER CELL CULTURE; DENGUE; DENGUE VIRUS 2; DOWN REGULATION; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; INTERFERON INDUCTION; NONHUMAN; PROTEIN FUNCTION; VIRUS REPLICATION; BIOSYNTHESIS; DENGUE VIRUS; FLUORESCENCE MICROSCOPY; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

DENGUE VIRUS;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DENGUE VIRUS; DNA PRIMERS; HUMANS; INTERFERON-BETA; LIGANDS; LIVER NEOPLASMS; MICROSCOPY, FLUORESCENCE; POLY I-C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TOLL-LIKE RECEPTOR 3; VIRUS REPLICATION;

EID: 79961140354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023346     Document Type: Article

References (44)

1. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
2. Gubler DJ, (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496.
3. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, et al. (2007) Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6: 975-990.
4. Ank N, West H, Paludan SR, (2006) IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26: 373-379.
5. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, et al. (2000) Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74: 4957-4966.
6. Johnson AJ, Roehrig JT, (1999) New mouse model for dengue virus vaccine testing. J Virol 73: 783-786.
7. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A, (2010) Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84: 4845-4850.
8. Tsai YT, Chang SY, Lee CN, Kao CL, (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11: 604-615.
9. Qin CF, Zhao H, Liu ZY, Jiang T, Deng YQ, et al. (2010) Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response. Mol Biol Rep.
10. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, et al. (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5: e926.
11. Uematsu S, Akira S, (2007) Toll-like receptors and Type I interferons. J Biol Chem 282: 15319-15323.
12. Blasius AL, Beutler B, (2010) Intracellular toll-like receptors. Immunity 32: 305-315.
13. Wu MH, Zhang P, Huang X, (2010) Toll-like receptors in innate immunity and infectious diseases. Front Med China 4: 385-393.
14. Xia C, Lu M, Zhang Z, Meng Z, Zhang Z, et al. (2008) TLRs antiviral effect on hepatitis B virus in HepG2 cells. J Appl Microbiol 105: 1720-1727.
15. Wu J, Lu M, Meng Z, Trippler M, Broering R, et al. (2007) Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46: 1769-1778.
16. Isogawa M, Robek MD, Furuichi Y, Chisari FV, (2005) Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79: 7269-7272.
17. Svensson A, Bellner L, Magnusson M, Eriksson K, (2007) Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection. J Reprod Immunol 74: 114-123.
18. Nazli A, Yao XD, Smieja M, Rosenthal KL, Ashkar AA, et al. (2009) Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women. Antiviral Res 81: 103-112.
19. Trapp S, Derby NR, Singer R, Shaw A, Williams VG, et al. (2009) Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J Virol 83: 884-895.
20. Zhou Y, Wang X, Liu M, Hu Q, Song L, et al. (2010) A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 131: 40-49.
21. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, et al. (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol 83: 9824-9834.
22. Lau YF, Tang LH, Ooi EE, Subbarao K, (2010) Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice. Virology 406: 80-87.
23. Boukhvalova MS, Sotomayor TB, Point RC, Pletneva LM, Prince GA, et al. (2009) Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model. J Interferon Cytokine Res 30: 229-242.
24. Chen YC, Wang SY, King CC, (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 73: 2650-2657.
25. Cabrera-Hernandez A, Thepparit C, Suksanpaisan L, Smith DR, (2007) Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70. J Med Virol 79: 386-392.
26. Modhiran N, Kalayanarooj S, Ubol S, (2011) Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis 4: e924.
27. Thepparit C, Phoolcharoen W, Suksanpaisan L, Smith DR, (2004) Internalization and propagation of the dengue virus in human hepatoma (HepG2) cells. Intervirology 47: 78-86.
28. Nishimura M, Naito S, (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28: 886-892.
29. Zhu J, Mohan C, (2010) Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm 2010: 781235.
30. Sariol CA, Martinez MI, Rivera F, Rodriguez IV, Pantoja P, et al. (2011) Decreased Dengue Replication and an Increased Anti-viral Humoral Response with the use of Combined Toll-Like Receptor 3 and 7/8 Agonists in Macaques. PLoS One 6: e19323.
31. Samuel CE, (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809 table of contents.
32. Silverman RH, (2007) Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81: 12720-12729.
33. Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, et al. (2009) Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection. J Immunol 183: 8035-8043.
34. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, et al. (2006) Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80: 4501-4509.
35. Bartlett NW, Buttigieg K, Kotenko SV, Smith GL, (2005) Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 86: 1589-1596.
36. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
37. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68.
38. Robek MD, Boyd BS, Chisari FV, (2005) Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79: 3851-3854.
39. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD, (2010) Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401: 197-206.
40. Munoz-Jordan JL, (2009) Subversion of interferon by dengue virus. Curr Top Microbiol Immunol 338: 35-44.
41. Conceicao TM, El-Bacha T, Villas-Boas CS, Coello G, Ramirez J, et al. (2010) Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect 60: 65-75.
42. Zhou JM, Tang YX, Fang DY, Zhou JJ, Liang Y, et al. (2006) Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris. Virus Genes 33: 27-32.
43. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene 27: 493-449.
44. Maul A, (1991) Aspects statistiques des méthodes de quantification en virologie. Virologie des milieux hydriques Tec & Doc- Lavoisier pp. 143-171.